We are live on
!
Find out more
RGLS
Regulus Therapeutics
RGLS
RGLS
Delisted
RGLS was delisted on the 24th of June, 2025.
28 hedge funds and large institutions have $2.71M invested in Regulus Therapeutics in 2019 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
14% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 7
11% more capital invested
Capital invested by funds: $2.44M → $2.71M (+$270K)
4% more funds holding
Funds holding: 27 → 28 (+1)
0% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 5
0.53% less ownership
Funds ownership: 3% → 2.47% (-0.53%)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $5K
Holders
28
Holders Change
+1
Holders Change %
+3.7%
% of All Funds
0.61%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
5
Reduced
5
Closed
7
Calls
–
Puts
$5K
Net Calls
-$5K
Net Calls Change
-$6K
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$126K |
| 2 |
VF
Virtu Financial
New York
|
+$72.4K |
| 3 |
Jane Street
New York
|
+$68.6K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$16.7K |
| 5 |
ARTA
A.R.T. Advisors
New York
|
+$12K |
Top Sellers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$197K |
| 2 |
Bank of New York Mellon
New York
|
-$25K |
| 3 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$21K |
| 4 |
Two Sigma Investments
New York
|
-$21K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$10K |
